Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


MDMA reimbursement advisory counsel

This article was originally published in The Gray Sheet

Executive Summary

Kathy Means, formerly senior public policy advisor for law firm Patton Boggs, joins the trade association to advise on reimbursement issues. Means takes over for Dan Waldmann, who joined J&J as director of federal affairs & reimbursement for medical devices June 2 (1"The Gray Sheet" May 19, 2003, In Brief)...

You may also be interested in...

MDMA consultant Kathy Means

Consultant on reimbursement issues remains at Patton Boggs. "The Gray Sheet" characterized Means as a former senior public policy advisor for the Washington, D.C. law firm (1"The Gray Sheet" June 9, 2003, In Brief)...

J&J’s D.C. reimbursement office

Daniel Waldmann of The Waldmann Group, consultant to St. Jude Medical and the Medical Device Manufacturers Association, becomes Johnson & Johnson director of federal affairs & reimbursement for medical devices June 2, overseeing the Cypher sirolimus-eluting stent and iBOT stair-climbing wheelchair. He joins Health Policy Director Greg White in J&J's Washington, D.C. office...

Recent eMDR Change By FDA Asks Adverse Event Reporters About Third-Party Servicers

The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts